Switch to:
More From Other Websites
1:57 am Pfizer reports new Phase 2 results show investigational compound Glasdegib; demonstrated... Dec 05 2016
Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions Dec 03 2016
New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute... Dec 03 2016
Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial... Dec 03 2016
[$$] New Tax Rules on Corporate Inversions Face Uncertain Future Dec 03 2016
$50 Billion Quant Fund Is Making New Bets On These Stocks Dec 02 2016
The Numbers Behind a Pharma CEO Shouting Match Dec 02 2016
Morgan Stanley: Chevron, Pfizer Will be Big Winners in 2017 Dec 02 2016
[$$] Tax Rules on Corporate Inversions Face Uncertain Future Dec 02 2016
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug Dec 02 2016
5 Best Dividend Stocks To Buy Right Now Dec 02 2016
The Word on the Street: What Analysts Are Estimating for Pfizer Now Dec 02 2016
Coverage initiated on Pfizer by Guggenheim Dec 02 2016
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda Dec 02 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016
Pharma execs weigh in on possible changes under Trump Dec 01 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK